T Scientific Co.Ltd Cash Flow-to-Debt Ratio
T Scientific Co.Ltd cash flow-to-debt ratio. T Scientific Co.Ltd (057680) has a Cash Flow-to-Debt Ratio of -0.05x as of September 2025, meaning its operating cash flow of ₩-1.14 Billion could theoretically repay 0% of its total liabilities (₩21.22 Billion) in one year. Check T Scientific Co.Ltd cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of T Scientific Co.Ltd (2009–2024)
Cash flow-to-debt ratio of T Scientific Co.Ltd from 2009 to 2024. Historical debt coverage capacity for T Scientific Co.Ltd across 13 annual periods. Check 057680 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
T Scientific Co.Ltd Cash Flow-to-Debt Ratio by Year (2009–2024)
T Scientific Co.Ltd cash flow-to-debt ratio by year from 2009 to 2024. Year-by-year debt coverage analysis for T Scientific Co.Ltd. For the full cash flow conversion analysis, see 057680 operating cash flow.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.57x | ₩-13.16 Billion | ₩22.95 Billion | ▼ -123.4% |
| 2023 | -0.26x | ₩-11.15 Billion | ₩43.43 Billion | ▼ -862.0% |
| 2022 | -0.03x | ₩-2.26 Billion | ₩84.57 Billion | ▼ -4620.3% |
| 2021 | 0.00x | ₩-42.06 Million | ₩74.39 Billion | ▲ +99.3% |
| 2020 | -0.08x | ₩-2.10 Billion | ₩25.01 Billion | ▼ -158.8% |
| 2019 | 0.14x | ₩3.39 Billion | ₩23.73 Billion | ▲ +68.0% |
| 2018 | 0.08x | ₩3.29 Billion | ₩38.76 Billion | ▲ +205.1% |
| 2017 | -0.08x | ₩-2.90 Billion | ₩35.91 Billion | ▼ -78.5% |
| 2016 | -0.05x | ₩-688.62 Million | ₩15.21 Billion | ▲ +76.8% |
| 2015 | -0.20x | ₩-2.77 Billion | ₩14.16 Billion | ▼ -118.2% |
| 2014 | -0.09x | ₩-865.90 Million | ₩9.67 Billion | ▲ +20.6% |
| 2013 | -0.11x | ₩-1.48 Billion | ₩13.10 Billion | ▼ -168.2% |
| 2009 | 0.17x | ₩1.16 Billion | ₩7.01 Billion | — |